Eli Lilly on Tuesday said it struck a $2.4 billion deal to acquire Dice Therapeutics...
70.2K
Verified Solution
Link Copied!
Question
Finance
Eli Lilly on Tuesday said it struck a $2.4 billion deal to acquire Dice Therapeutics in a bid to bulk up its treatment portfolio for immune-related diseases. S Dice is a biopharmaceutical company that uses a proprietary technology platform to develop new oral therapeutic drugs for autoimmune diseases, in which the body's immune system mistakenly attacks a person's own cells instead of protecting them. Eli Lilly's immunology potfolio includes drugs such as Taltz, which treats plaque psoriasis, and Olumiant
Answer & Explanation
Solved by verified expert
Get Answers to Unlimited Questions
Join us to gain access to millions of questions and expert answers. Enjoy exclusive benefits tailored just for you!
Membership Benefits:
Unlimited Question Access with detailed Answers
Zin AI - 3 Million Words
10 Dall-E 3 Images
20 Plot Generations
Conversation with Dialogue Memory
No Ads, Ever!
Access to Our Best AI Platform: Flex AI - Your personal assistant for all your inquiries!
